Flywheel’s new SaaS platform is integrated with Nvidia MONAI, a part of the Nvidia AI Enterprise software platform, and Azure Machine Learning Studio, to enable the development and deployment of production-grade AI applications
Flywheel partners with Microsoft and Nvidia. (Credit: National Cancer Institute on Unsplash)
US-based AI medical imaging platform Flywheel, in collaboration with Nvidia and Microsoft, has launched its software-as-a-service (SaaS) data management solution on Microsoft Azure.
The SaaS platform is integrated with Nvidia MONAI and Azure Machine Learning Studio to enable the development and deployment of production-grade AI applications.
MONAI is a set of open-source, freely available collaborative frameworks that help advance research and clinical collaboration in medical imaging.
Nvidia MONAI is a part of the Nvidia AI Enterprise software platform.
The new SaaS offering, created based on Flywheel’s existing managed service that has been available since 2015, is expected to bring significant advancements in medical imaging research and AI model development across the healthcare ecosystem.
Flywheel chief revenue officer Trent Norris said: “We are standing on the cusp of a revolution in healthcare, poised to leverage the vast potential of medical imaging data.
“But harnessing this potential responsibly means ensuring the data is meticulously managed, accurately labelled, diligently curated, and rigorously tested. It’s a matter of trust. Our collaboration with Microsoft and Nvidia epitomizes this commitment.
“The synergy between Microsoft Azure Machine Learning, Nvidia MONAI and Microsoft’s advanced services creates a robust platform that is integral to our mission. This unified approach is not just about technology.
Flywheel provides advanced infrastructure for the curation of high-quality, standardised datasets within a secure, scalable, and user-friendly SaaS solution.
The platform advances the process of preparing and training data for AI model development and supports research among pharmaceutical and life sciences companies, research institutions, and healthcare providers.
Flywheel said that its collaboration with Microsoft and Nvidia helps researchers and healthcare professionals mitigate the barriers and advance the management, curation, and analysis of medical imaging data.
The company has launched the new SaaS solution on the Azure Marketplace, pursuant to an agreement it has signed with Microsoft.
Its solutions integrate with Azure Machine Learning MLOps capabilities and Nvidia MONAI to support clinical AI collaboration, eliminating redundant model-building workflows.
Furthermore, Flywheel can enhance patient cohort discovery and enrich images with refined data from radiology reports, using mPower Clinical Analytics by Nuance, a Microsoft company.
Microsoft health and life sciences corporate vice president Peter Durlach said: “Flywheel’s expertise in medical imaging, combined with the power and scale of Azure, along with the advanced imaging analytics capabilities of mPower, is ushering in a new era of healthcare innovation.
“Our partnership is geared towards a future where Flywheel’s platform combined with Microsoft’s cloud and AI capabilities will help transform patient care through accelerated discovery and AI-driven insights.”